Phibro reveals gameplan to sustain strong growth
Phibro Animal Health recently reported 8% growth in sales in its fiscal third quarter. This was a continuation of a strong 2015 so far. The firm's chief financial officer (CFO), Richard Johnson, gave an overview of how this growth was achieved and how it will be maintained, when addressing the Bank of America Merrill Lynch 2015 Health Care Conference. Animal Pharm Editor Joseph Harvey listened in.